Paul Goldsmith

Discovery of 2-[(2,4-Dichlorophenyl)amino]- <i>N</i> -[(tetrahydro- 2 <i>H</i> -pyran-4-yl)methyl]-4-(trifluoromethyl)- 5-pyrimidinecarboxamide, a Selective CB2 Receptor Agonist for the Treatment of Inflammatory Pain

Gerard M.P. Giblin, Celestine T. O’Shaughnessy, Alan Naylor et al. · Journal of Medicinal Chemistry · 2007 · 120 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Effects of Pan- and Subtype-Selective N-Methyl-d-aspartate Receptor Antagonists on Cortical Spreading Depression in the Rat: Therapeutic Potential for Migraine

Magali Peeters, Martin J. Gunthorpe, Paul J. L. M. Strijbos et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 115 citations

Life Sciences, Neuroscience, Pharmacology +16

The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthma

Veit J. Erpenbeck, Todor A. Popov, David Miller et al. · Pulmonary Pharmacology & Therapeutics · 2016 · 109 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Prophylactic biological mesh reinforcement versus standard closure of stoma site (ROCSS): a multicentre, randomised controlled trial

Aneel Bhangu, Dmitri Nepogodiev, Natalie Ives et al. · The Lancet · 2020 · 80 citations · Full text

Medicine, Surgery, General Surgery +16

Non-acidic pyrazole EP1 receptor antagonists with in vivo analgesic efficacy

Adrian Hall, Andy Billinton, Susan H. Brown et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 76 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13